Bell Biosystems Lands $2,058,230 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6b34a79b-55c5-4fd6-904d-4ff3f3861d1f
Date
1/8/2014
Company Name
Bell Biosystems
Mailing Address
953 Indiana Street San Francisco, CA 94107
Company Description
Bell Biosystems combines expertise in stem cell research, cell biology, oncology, biomedical imaging and molecular biology. Our vision is to create tools that accelerate the “bench-to-bedside” progress of innovations in oncology and cell therapy research.
Website
http://www.bellbiosystems.com
Transaction Type
Venture Equity
Transaction Amount
$2,058,230
Transaction Round
Series A
Proceeds Purposes
Proceeds purposes were not disclosed. Includes conversion of convertible promissory notes. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed